Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Gains from Investment Securities (2016 - 2025)

Eastman Chemical (EMN) has disclosed Gains from Investment Securities for 14 consecutive years, with -$20.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities changed N/A year-over-year to -$20.0 million, compared with a TTM value of -$25.0 million through Dec 2025, down 38.89%, and an annual FY2025 reading of -$25.0 million, down 38.89% over the prior year.
  • Gains from Investment Securities was -$20.0 million for Q4 2025 at Eastman Chemical, down from -$5.0 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $19.0 million in Q1 2023 and bottomed at -$30.0 million in Q3 2023.
  • Average Gains from Investment Securities over 5 years is -$4.1 million, with a median of -$3.0 million recorded in 2021.
  • Peak annual rise in Gains from Investment Securities hit 1200.0% in 2022, while the deepest fall reached 500.0% in 2022.
  • Year by year, Gains from Investment Securities stood at $1.0 million in 2021, then surged by 1200.0% to $13.0 million in 2022, then plummeted by 330.77% to -$30.0 million in 2023, then soared by 40.0% to -$18.0 million in 2024, then fell by 11.11% to -$20.0 million in 2025.
  • Business Quant data shows Gains from Investment Securities for EMN at -$20.0 million in Q4 2025, -$5.0 million in Q1 2025, and -$18.0 million in Q3 2024.